Sangamo Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and a Favorable Safety Profile

Miles’ Story
Hemophilia A

Hemophilia A

June 12th, 2021

June 12th, 2021